Metropolitan Life Insurance CO Biocryst Pharmaceuticals Inc Transaction History

Metropolitan Life Insurance CO

  • $281 Million
  • Q3 2024

Shares

50 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$4.89 - $7.65 $7,555 - $11,819
-1,545 Reduced 13.28%
10,087 $51,000
Q3 2023

Nov 14, 2023
BUY
$6.71 - $7.92 $10,762 - $12,703
1,604 Added 16.0%
11,632 $82,000
Q1 2023

May 15, 2023
SELL
$7.94 - $11.84 $11,417 - $17,025
-1,438 Reduced 12.54%
10,028 $83,000
Q4 2022

Jun 14, 2023
BUY
$10.5 - $14.2 $15,099 - $20,419
1,438 Added 14.34%
11,466 $132 Million
Q4 2022

Mar 30, 2023
BUY
$10.5 - $14.2 $3,822 - $5,168
364 Added 3.28%
11,466 $131,000
Q4 2022

Feb 15, 2023
BUY
$10.5 - $14.2 $3,822 - $5,168
364 Added 3.28%
11,466 $131,000
Q3 2022

Jun 14, 2023
BUY
$10.79 - $14.81 $11,588 - $15,905
1,074 Added 10.71%
11,102 $140 Million
Q2 2022

Jun 20, 2023
BUY
$7.89 - $17.88 $8,473 - $19,203
1,074 Added 10.71%
11,102 $117,000
Q1 2022

Jun 20, 2023
BUY
$11.56 - $19.76 $12,415 - $21,222
1,074 Added 10.71%
11,102 $180,000
Q1 2022

Mar 30, 2023
SELL
$11.56 - $19.76 $419,234 - $716,616
-36,266 Reduced 76.56%
11,102 $180,000
Q1 2022

May 12, 2022
SELL
$11.56 - $19.76 $419,234 - $716,616
-36,266 Reduced 76.56%
11,102 $181,000
Q4 2021

Jun 21, 2023
BUY
$11.18 - $15.46 $417,461 - $577,276
37,340 Added 372.36%
47,368 $656,000
Q3 2021

Jun 21, 2023
BUY
$14.21 - $17.65 $530,601 - $659,051
37,340 Added 372.36%
47,368 $680,000
Q3 2021

Mar 30, 2023
SELL
$14.21 - $17.65 $66,872 - $83,060
-4,706 Reduced 9.04%
47,368 $680,000
Q3 2021

Nov 15, 2021
SELL
$14.21 - $17.65 $66,872 - $83,060
-4,706 Reduced 9.04%
47,368 $681,000
Q2 2021

Jun 21, 2023
BUY
$9.5 - $17.24 $399,437 - $724,873
42,046 Added 419.29%
52,074 $823,000
Q2 2021

Mar 30, 2023
BUY
$9.5 - $17.24 $38,845 - $70,494
4,089 Added 8.52%
52,074 $823,000
Q2 2021

Aug 16, 2021
BUY
$9.5 - $17.24 $494,247 - $896,928
52,026 Added 108387.5%
52,074 $823,000
Q1 2021

Jun 26, 2023
BUY
$7.37 - $13.61 $279,743 - $516,594
37,957 Added 378.51%
47,985 $488 Million
Q1 2021

Mar 30, 2023
SELL
$7.37 - $13.61 $25,677 - $47,417
-3,484 Reduced 6.77%
47,985 $488,000
Q1 2021

May 14, 2021
SELL
$7.37 - $13.61 $378,972 - $699,839
-51,421 Reduced 99.91%
48 $488,000
Q4 2020

Jun 22, 2023
BUY
$3.37 - $8.61 $139,656 - $356,807
41,441 Added 413.25%
51,469 $383,000
Q4 2020

Mar 30, 2023
SELL
$3.37 - $8.61 $7,835 - $20,018
-2,325 Reduced 4.32%
51,469 $383,000
Q4 2020

Feb 16, 2021
SELL
$3.37 - $8.61 $7,835 - $20,018
-2,325 Reduced 4.32%
51,469 $383,000
Q3 2020

Jun 26, 2023
BUY
$3.43 - $5.53 $150,117 - $242,025
43,766 Added 436.44%
53,794 $185,000
Q3 2020

Mar 30, 2023
BUY
$3.43 - $5.53 $10,650 - $17,170
3,105 Added 6.13%
53,794 $185,000
Q3 2020

Nov 13, 2020
BUY
$3.43 - $5.53 $10,650 - $17,170
3,105 Added 6.13%
53,794 $185,000
Q2 2020

Jun 26, 2023
BUY
$1.9 - $5.61 $77,255 - $228,108
40,661 Added 405.47%
50,689 $241,000
Q2 2020

Mar 30, 2023
SELL
$1.9 - $5.61 $1 - $5
-1 Reduced -0.0%
50,689 $241,000
Q2 2020

Aug 14, 2020
SELL
$1.9 - $5.61 $1 - $5
-1 Reduced -0.0%
50,689 $242,000
Q1 2020

Jul 12, 2023
BUY
$1.6 - $4.11 $65,059 - $167,120
40,662 Added 405.48%
50,690 $101,000
Q1 2020

Mar 30, 2023
BUY
$1.6 - $4.11 $500 - $1,286
313 Added 0.62%
50,690 $101,000
Q1 2020

May 15, 2020
BUY
$1.6 - $4.11 $500 - $1,286
313 Added 0.62%
50,690 $101,000
Q4 2019

Jul 12, 2023
BUY
$1.59 - $3.45 $64,154 - $139,204
40,349 Added 402.36%
50,377 $173,000
Q4 2019

Mar 30, 2023
BUY
$1.59 - $3.45 $21,315 - $46,250
13,406 Added 36.26%
50,377 $173,000
Q4 2019

Feb 14, 2020
BUY
$1.59 - $3.45 $21,315 - $46,250
13,406 Added 36.26%
50,377 $174,000
Q3 2019

Jul 12, 2023
BUY
$2.5 - $3.73 $67,357 - $100,497
26,943 Added 268.68%
36,971 $106,000
Q2 2019

Jul 12, 2023
BUY
$2.91 - $9.15 $78,404 - $246,528
26,943 Added 268.68%
36,971 $140,000
Q1 2019

Jul 13, 2023
BUY
$7.38 - $9.72 $198,839 - $261,885
26,943 Added 268.68%
36,971 $300,000
Q1 2019

Mar 30, 2023
BUY
$7.38 - $9.72 $188,226 - $247,908
25,505 Added 222.44%
36,971 $300,000
Q1 2019

May 16, 2019
BUY
$7.38 - $9.72 $154,758 - $203,828
20,970 Added 131.05%
36,971 $300,000
Q1 2019

May 15, 2019
SELL
$7.38 - $9.72 $154,758 - $203,828
-20,970 Reduced 56.72%
16,001 $1.11 Million
Q4 2018

Jul 13, 2023
BUY
$6.51 - $9.6 $175,398 - $258,652
26,943 Added 268.68%
36,971 $298,000
Q4 2018

Feb 14, 2019
BUY
$6.51 - $9.6 $193,249 - $284,976
29,685 Added 407.43%
36,971 $298,000
Q3 2018

Jul 13, 2023
BUY
$5.52 - $7.99 $142,835 - $206,749
25,876 Added 258.04%
35,904 $274 Million
Q3 2018

Nov 14, 2018
SELL
$5.52 - $7.99 $132,634 - $191,983
-24,028 Reduced 76.73%
7,286 $56,000
Q1 2018

May 15, 2018
BUY
$4.35 - $5.82 $19,535 - $26,137
4,491 Added 16.74%
31,314 $0
Q4 2017

Feb 15, 2018
SELL
$4.16 - $5.33 $138,332 - $177,238
-33,253 Reduced 55.35%
26,823 $132,000
Q3 2017

Nov 14, 2017
SELL
$4.1 - $5.97 $204 - $298
-50 Reduced 0.08%
60,076 $315,000
Q2 2017

Aug 14, 2017
BUY
N/A
60,126
60,126 $334,000

Others Institutions Holding BCRX

# of Institutions
279
Shares Held
172M
Call Options Held
625K
Put Options Held
739K
View Full List

About BIOCRYST PHARMACEUTICALS INC

BCRX Quotes by TradingView
  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.41B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email